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Abstract: 
1-Phenyl-2-propanone (P2P) is an internationally monitored precursor that 
has become increasingly difficult for illicit amphetamine producers to 
source, which means that alternative routes to its preparation become 
increasingly important. One such approach includes the hydrolysis of 
alpha-phenylacetoacetonitrile (APAAN) with sulfuric acid. Previously, we 
reported the identification of 4,6-dimethyl-3,5-diphenylpryid-2-one 
following implementation of hydrolysis conditions and it was proposed that 
this compound might serve as one route specific by-product in the APAAN 
to P2P conversion. This study continued to explore the presence of 
impurities formed during this conversion and expanded also into a second 
route of P2P synthesis starting from alpha-methylstyrene (AMS). All P2P 
products underwent the Leuckart procedure to probe the presence of P2P-
relted impurities that might have carried through to the final product. Two 
by-products associated with the APAAN hydrolysis route to P2P were 
identified as 2,3-diacetyl-2,3-diphenylsuccinonitrile (1) and 2-methyl-1-
phenyl-1,3-dicarbonitrile-1H-indene (2). Two by-products associated with 
the AMS route to P2P and subsequent Leuckart reaction were 1,1,3-
trimethyl-3-phenyl-2,3-dihydro-1H-indene (3) and 1-phenyl-N-
(phenylethyl)propan-2-amine (4), respectively. The two indenes (2 and 3) 
identified in synthesized amphetamine originating from P2P suggested that 
it might be possible to differentiate between the two synthetic routes 
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regarding the use of APAAN and AMS. Furthermore, the association of 
these compounds with amphetamine production appears to have been 
reported for the first time. The presence of compounds 1 – 4 in seized 
amphetamine samples and waste products could facilitate the suggestion 
whether APAAN or AMS were employed in the synthesis route to the P2P.  
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Figure 1. Compounds (1) and (2) and proposed formation mechanism of  (2) during pyrolysis of (1).  
132x89mm (300 x 300 DPI)  
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Figure 2. A: GCMS trace of a representative APAAN hydrolysis to P2P (GC-MS method 1). B: Electron 
ionization mass spectrum of compound (2). C: Proposed fragmentation pattern of compound (2).  
249x337mm (300 x 300 DPI)  
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Figure 3. X-ray structures for (1) and (2).  
231x319mm (300 x 300 DPI)  
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Figure 4. A: 1,2-phenyl shift to yield P2P via an iodosyl intermediate. B: Electron ionization mass spectrum 
of (3). C: Proposed fragmentation pattern of compound (3).  
269x374mm (300 x 300 DPI)  
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Figure 5. Proposed mechanism of formation of compound (4) during Leuckart reaction.  
92x41mm (300 x 300 DPI)  
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Abstract 
 
1-Phenyl-2-propanone (P2P) is an internationally monitored precursor that has become 
increasingly difficult for illicit amphetamine producers to source, which means that 
alternative routes to its preparation become increasingly important. One such approach 
includes the hydrolysis of alpha-phenylacetoacetonitrile (APAAN) with sulfuric acid. 
Previously, we reported the identification of 4,6-dimethyl-3,5-diphenylpryid-2-one following 
implementation of hydrolysis conditions and it was proposed that this compound might 
serve as one route specific by-product in the APAAN to P2P conversion. This study 
continued to explore the presence of impurities formed during this conversion and 
expanded also into a second route of P2P synthesis starting from alpha-methylstyrene 
(AMS). All P2P products underwent the Leuckart procedure to probe the presence of P2P-
related impurities that might have carried through to the final product. Two by-products 
associated with the APAAN hydrolysis route to P2P were identified as 2,3-diacetyl-2,3-
diphenylsuccinonitrile (1) and 2-methyl-1-phenyl-1,3-dicarbonitrile-1H-indene (2), 
respectively. Two by-products associated with the AMS route to P2P and subsequent 
Leuckart reaction were 1,1,3-trimethyl-3-phenyl-2,3-dihydro-1H-indene (3) and 1-phenyl-N-
(phenylethyl)propan-2-amine (4), respectively. The two indenes (2 and 3) identified in 
synthesized amphetamine originating from P2P sugges ted  t ha t  i t  m ight  be 
poss ib le  t o  d i f f e ren t ia te  between t he  two synthetic routes regarding the use of 
APAAN and AMS. Furthermore, the association o f  these  compounds with amphetamine 
production appears to have been reported for the first time. The presence of compounds 1 
– 4 in seized amphetamine samples and waste products could facilitate the suggestion 
whether APAAN or AMS were employed in the synthesis route to the P2P.  
 
Keywords: APAAN, alpha-methylstyrene, P2P, impurities, cyclic indene 
 
Running title: Formation of indene derivatives during synthesis of P2P and amphetamine 
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Introduction 
 
1-Phenyl-2-propanone (P2P, benzylmethylketone, BMK) is a known precursor used in 
assorted amphetamine related synthesis routes.[1,2] The Leuckart synthesis route utilizing 
P2P as the starting material is widely employed by illicit amphetamine and 
methamphetamine producers in Europe, and increasingly so in America.[3] There are 
many known synthesis routes to P2P and the most frequently encountered methods are 
those starting from phenylacetic acid, benzyl cyanide and benzaldehyde, respectively.[4] 
Commercial trade in P2P is internationally monitored by law enforcement authorities. As 
the traditional precursors to amphetamine-type illicit substances are under increased 
scrutiny, it is common for illicit producers to turn to alternative substances as starting 
materials. alpha-Phenylacetoacetonitrile (APAAN), is an example of one such alternative 
starting material for illicit amphetamine manufacture.[5] APAAN can easily be converted 
to the more desirable starting material P2P and this may also occur at an amphetamine 
production site. Increasingly, dedicated ‘APAAN to P2P’ production sites are increasingly 
encountered in non-adjoining premises in an attempt to segregate the different synthesis 
stages in clandestine manufacture and to hinder investigations by law enforcement 
agencies.[6]  
The scale of the use of APAAN in illicit amphetamine can be estimated by an 
examination of shipment and seizure data. Shipments of APAAN seized in European 
countries included Poland (800 kg seized in 2010–11), Bulgaria (940 kg seized in 2012), 
Germany (500 kg in 2012), Hungary (3,000 kg in 2012) and Belgium (23 individual 
APAAN seizures in 2012). In addition, many clandestine facilities, found to employ the 
APAAN to P2P conversion have been dismantled in across Europe.[7] Conversely, the 
confiscated amounts of P2P have decreased dramatically throughout Europe from 
approximately 5,000 L in 2010 to just 32 L in 2013. APAAN was placed under control in 
the European Union at the end of 2013. In March 2014, the Commission on Narcotic 
Drugs of the United Nations voted unanimously in favor of placing APAAN under 
international control.[7] In 2013, more than 48,000 kg of APAAN was seized using 
varying types of legislation. [5] The Commission on Narcotic Drugs noted that legitimate 
uses for APAAN are very limited, and therefore any large imports to Europe were likely 
to be intended for conversion to P2P. One liter of APAAN yields an estimated 0.7 L of 
P2P and noting the actual seizures of APAAN in Europe, a concern is that vast 
quantities of amphetamine or methamphetamine could have been manufactured from 
APAAN in recent years.[6,7] 
 
The majority of illicit drugs contain impurities that originate from either the synthesis 
route employed, impurities present in raw materials or from the post-production 
process.[1] It is essential for the investigation of illicit drug production that information on 
manufacturing methods, new synthesis routes, the identification of by-products, 
impurities, new starting materials, contaminants and diluents are collated, reported and 
made available in the literature for dissemination. There is little information available in 
the scientific literature about synthetic routes to APAAN or on any by-products that might 
be formed during its manufacture. Therefore, identification of route-specific impurities 
would be helpful for investigations linked to cases involving clandestine laboratories.  
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Previously, our group reported the ident i f i cat ion of  4,6-dimethyl-3,5-diphenylpyrid-
2-one, an impurity found after acidic hydrolysis of APAAN, which indicated that it might 
serve as a possible route specific by-product that could remain present in the final 
amphetamine product.[8] The present investigation extends our research efforts into the 
identification of impurities that might be formed during acidic hydrolysis of APAAN for 
amphetamine production. In addition, we also investigated a recently reported method, 
which utilized arylalkene starting materials, where Oxone® (potassium 
peroxymonosulfate) and sodium iodide were employed to form the corresponding 
arylketones in high yield.[9] This method would, in our opinion, seem promising from an 
illicit P2P manufacturers viewpoint, if alpha-methylstyrene (AMS) was used as the 
starting material. It is readily available and not monitored by authorities and Oxone® is a 
commercially available pool cleaning agent.  
This study reports on the identification of by-products formed during APAAN hydrolysis 
and the identificati n and characterization of 2,3-diacetyl-2,3-diphenylsuccinonitrile (1) 
and 2-methyl-1-phenyl-1,3-dicarbonitrile-1H-indene (2). In addition, 1,1,3-trimethyl-3-
phenyl-2,3-dihydro-1H-indene (3) and 1-phenyl-N-(1-phenylethyl)propan-2-amine (4) 
were identified as by-products in the Leuckart reaction of the P2P generated from the 
AMS synthesis route. The impact on product formation was investigated when changing 
the concentration of sodium iodide employed in the AMS to P2P procedure.  
 
Experimental 
Reagents and standards 
 
All reagents, dry solvents and 1,1,3-trimethyl-3-phenyl-2,3-dihydro-1H-indene (3) were 
obtained from Sigma Aldrich Ltd. (Arklow, Ireland). LCMS grade solvents were obtained 
from Fisher Scientific (Dublin, Ireland). 
 
Syntheses and isolation 
 
Hydrolysis of APAAN with 50 % (v/v) aqueous sulfuric acid 
 
A mixture of APAAN (1.0 g, 6.3 mmol) and aqueous sulfuric acid (50 % (v/v), 12 mL) was 
heated (oil bath at 120 °C), with constant stirring, for 4 h. The mixture was allowed to 
cool to room temperature and dichloromethane was added. The organic layer was 
collected, washed with aqueous sodium hydroxide (2 M), dried (anhydrous magnesium 
sulfate) and removed to afford a brown oil (460 mg) that represented the crude 
hydrolysis product of APAAN including P2P and by-products. 
 
General procedure for the isolation of compounds (1) and (2) from APAAN, P2P and 
amphetamine by preparative TLC 
Samples (200 mg) were fractionated by preparative silica gel thin layer chromatography 
(cyclohexane/ethyl acetate, 200/10) to collect bands corresponding to Rf values of 
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compounds (1) and (2). For the analysis of the (2) band, the extracts were reconstituted 
and diluted appropriately with dichloromethane for GCMS analysis. For the analysis of 
the (1) band, the extracts were reconstituted in acetonitrile/water 1/1, containing 0.1 % 
formic acid for LCMS analysis.  
 
 
The effect of concentrated aqueous hydrochloric acid or 50 % (v/v) aqueous sulfuric acid 
on compounds (1) and (2). 
 
A mixture of (1) or (2) (5 mg) and concentrated aqueous hydrochloric acid (100 µL) or 50 
% (v/v) aqueous sulfuric acid was heated at 110 °C for 6 h. The mixture was allowed to 
cool to room temperature, diluted with water, made basic with aqueous sodium 
hydroxide (10 M) and extracted into dichloromethane. The product originating from the 
reaction with (1), the organic layer was collected, blown to dryness with nitrogen and the 
residue was reconstituted in acetonitrile/water (1/1, containing 0.1 % formic acid) for 
LCMS analysis. The product originating from the reaction with (2) was analyzed by 
GCMS. 
Formation of P2P by oxidation of alpha-methylstyrene (‘mixture A’ and ‘mixture B’) 
 
Oxone® (30.7 g, 0.1 mol) and sodium iodide (0.005 mol, 0.75 g) were added to a 
solution of AMS (5.90 g, 0.05 mol), in acetonitrile/water (5/1, 200 mL) and stirred for 8 
h at room temperature. The mixture was initially light brown, then colorless and turned 
brown again after approximately 7 h, diluted with water (500 mL) and extracted with 
dichloromethane. The organic extract was washed with aqueous sodium thiosulfate 
solution, dried (anhydrous magnesium sulfate) and the solvent was removed to afford 
a light yellow oil. The P2P content in the reaction product (‘mixture A’, 6.22 g) was 
estimated at 84 % based on a comparison with P2P reference material using three 
concentration levels. For the preparation of ‘mixture B’, a ten-fold higher concentration 
of sodium iodide (7.5 g, 0.05 mol) was used under identical reaction conditions. A 
yellow oil (10.85 g), was obtained and found to contain 5 % P2P. 
 
Isolation of (3) from P2P and its Leuckart reaction mixture by preparative TLC 
Samples (200 mg) were fractionated by preparative silica gel TLC (hexane) to collect the 
band corresponding to the Rf value of compound (3). The extracts were evaporated and 
re-constituted in dichloromethane for GCMS analysis. 
 
Leuckart reaction with P2P obtained from different synthetic routes 
 
A mixture of the corresponding P2P product (1.0 g), formamide (1.0 g, 0.022 mol) and 
formic acid (1.0 g, 0.022 mol) was heated (oil bath at 150 °C) for 4 h. The mixture was 
allowed to cool to room temperature. Concentrated aqueous hydrochloric acid (10 mL) 
was added and the mixture was heated (oil bath 110 °C) for 2 h. The mixture was 
allowed to cool to room temperature, diluted with water and made basic with aqueous 
sodium hydroxide (10 M) and extracted with dichloromethane. The organic layer was 
pooled, dried (anhydrous magnesium sulfate) and the solvent was removed. The P2P 
products were prepared from the procedures described above: a) ‘mixture A’ (AMS 
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oxidation, 563 mg of a brown oil); b) commercially available P2P (718 mg of a brown oil); 
c) APAAN hydrolysis (770 mg of a brown oil); ‘mixture B’ (AMS oxidation with increased 
NaI; 965 mg of a brown oil).  
 
Exposure of compound (2) to Leuckart reaction conditions 
 
A mixture of compound (2) (10 mg), formamide (150 µL) and formic acid (150 µL was 
heated (oil bath at 120 °C) for 4 h. Concentrated aqueous hydrochloric acid (500 µL) 
was then added and heating was continued for 2 h. The mixture was allowed to cool to 
room temperature, diluted with water, made basic (sodium hydroxide) and extracted into 
dichloromethane. Drying (anhydrous magnesium sulfate) followed by removal of solvent 
yielded a yellow oil, which was analyzed by GCMS. 
 
Syntheses of compounds (1), (2) and (4) 
Synthesis methods used for compounds (1), (2) and (4) and 1-iodo-2-phenylpropan-2-ol 
are summarized as supplemental data 1. Compound 3 was commercially available. 
 
Instrumental analysis 
 
Gas chromatography - mass spectrometry (method 1) 
 
Samples were analyzed on an Agilent 6890N gas chromatograph coupled to a 5973 
MSD. A HP-5MS column (30 m × 0.25 mm × 0.25 µm) was used in split-less mode with 
helium carrier gas at a constant flow of 1 mL/min. The injection port and transfer line 
temperatures were set at 250 °C and 280 °C respectively. The initial oven temperature 
was 40 °C, held for 1 min, then ramped at 12 °C/min to 280 °C and held for 5 min, 
followed by a ramp of 20 °C/min to 300 °C with a final hold time of 3 min. The mass 
spectra data was collected after a solvent delay of 5 min. The ionization energy was set 
at 70 eV and the mass range was m/z 40-800. 
 
 
Liquid chromatography - mass spectrometry 
 
LCMS analyses, equipped with an electrospray ionization source, were performed on an 
Agilent 1100 LC system. The column (Allure PFP Propyl, 5 µm, 50 × 2.1 mm) was from 
Restek (Bellefonte, PA, USA) and the aqueous mobile phase A consisted of 0.05% 
formic acid in water whereas mobile phase B was prepared from 0.05% formic acid in 
acetonitrile, respectively. The Agilent LCMSD settings were as follows: positive 
electrospray mode, capillary voltage 3000 V, drying gas (N2) 12 L/min at 350 °C, 
nebulizer gas(N2) pressure 60 psi, m/z 50-500,  fragmentor  voltage 180 V. Samples for 
LC- MS analysis (2 µL injection volume) were dissolved in acetonitrile/water (1:1, 
containing 0.1% formic acid) at a concentration of 5 µg/mL. The following gradient 
elution program was used: 0-5 min 12% A and then increased to 35% over 30 min using 
a linear gradient. The flow rate was 1 mL/min and the column temperature was 30°C. 
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Nuclear magnetic resonance spectroscopy 
Samples were prepared in DMSO-d6 
1H (600 MHz) and 13C (150 MHz) NMR spectra 
were recorded on a Bruker AV600 NMR spectrometer using a 5 mm TCI cryoprobe. 
1
H 
NMR spectra were referenced to an external TMS reference at δ = 0 ppm. 
 
High-resolution electrospray mass spectrometry 
 
HR-ESI mass spectra were recorded by direct injection into a LTQ Orbitrap Discovery 
(Thermo Fisher, UK). Samples were dissolved in acetonitrile/water (1:1, containing 0.1 % 
formic acid) and infused at a rate of 5 µL/min. Full accurate high-resolution (30000) mass 
scans were performed in positive electrospray mode. Measured accurate masses were 
within ± 5ppm of the theoretical masses. The following conditions were used: drying gas 
(N2) 10000 mL/min, capillary temperature 310 °C, spray voltage 4 V, capillary voltage 22 
V and tube lens 77 V. 
 
X-ray crystallography 
 
A crystal was mounted on a MiTeGen micromount and data collected using a Bruker 
APEX Duo CCD diffractometer equipped with an Oxford Cobra cryosystem. Data were 
collected using ω and ϕ scans, corrected for Lorentz and polarization effects, and 
integrated using the Bruker APEX program suite.[10] Structures were solved by direct 
methods and refined with least squares procedures.[11] All non-hydrogen  atoms  were  
refined  anisotropically  and  hydrogen  atoms  were placed geometrically in the 
calculated positions using a riding model. 
 
Compound (1): colorless plate, 0.040 x 0.100 x 0.270mm, T = 100(2)K, C20H16N2O2, M = 
316.35, Mokα radiation (0.71073Å), monoclinic, P21/c, a = 9.0836(4), b = 16.5254(7), c 
= 11.0183(5)Å, β = 98.8792(18)°, V = 1634.14(12)Å3, Z = 4, ρ = 1.286 mg/m
3, µ = 0.084 
mm-1  reflections collected 46288, (θmax = 26.40°, 0.80 Å resolution), independent 
reflections 3353, R(int) = 0.0990, S = 1.036, R1 = 0.0475, wR2 = 0.1018.* 
 
Compound (2): colorless needle, 0.080 x 0.110 x 0.200mm, T = 100(2)K, C18H12N2, M = 
256.30, Mokα radiation (0.71073Å), orthorhombic, P212121, a = 8.7061(3), b= 
11.6316(4), c = 26.4065(9)Å, V = 2674.08(16) Å3, Z = 8, ρ = 1.273mg/m3, µ = 0.076 
mm-1,  reflections  collected  =  81867,  (θmax  =  26.54°,  0.80  Å resolution), 
independent reflections 5536, R(int) = 0.0584, S = 1.048, R1 = 0.0359, wR2 = 0.0785. (* 
R1=Σ||Fo|-|Fc|| / Σ |Fo| and wR2 = Σw(|Fo|2-|Fc|2)2/ Σw|Fo|2)1/2).  
Cambridge Crystallographic Data Centre deposition numbers 1407791 and 1407792 
contain the crystallographic data reported in this study.[12] 
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Results and discussion 
In this study, impurities associated with samples derived from the hydrolysis of APAAN 
to P2P followed by the Leuckart reaction were investigated and questions arose about 
the presence of by-products carried through to the final amphetamine product. Indeed, 
along with previously reported Leuckart synthesis by-products (most notably 
naphthalenes, di-phenylisopropylamines and formyl-amphetamines) another by-product 
4,6-dimethyl-3,5-diphenylpyridin-2-one was recently detected in the APAAN to P2P 
hydrolysis.[8]  
The commercially supplied reagent APAAN utilized in the experiments was stated to be 
greater than 98% in purity although the synthesis method was not specified. It was 
noticeable that the commercial APAAN sample also contained darker crystals amongst 
the off-white material. Analysis by LCMS revealed the presence of the expected APAAN 
peak but also the appearance of two compounds (1) and (2) with protonated molecules 
at m/z 317 and m/z 257, respectively. Interestingly, an analysis by GCMS, however, did 
not reveal a chromatographic peak corresponding to a  m o lecu lar  ion  a t  m/z 316 
(1). Only two peaks related to APAAN and (2) were observed which suggested that (1) 
was unstable under GCMS conditions.  
In each of the subsequent acidic hydrolysis (HCl and H2SO4) experiments conducted 
with APAAN, compound (1) was detected in the GCMS chromatograms. Analysis of 
synthesized (1) by GCMS revealed that it was fully converted to a mixture of APAAN and 
(2). The two compounds (1) and (2) were identified by chromatographic comparison as 
2,3-diacetyl-2,3-diphenylsuccinonitrile, a symmetrical dimer of APAAN, and 2-methyl-1-
phenyl-1,3 dicarbonitrile-1H-indene, respectively (supplemental data 2). 
Exposure of (1) to the GC analysis led to pyrolysis and it is proposed that this conversion 
might involve a structural rearrangement via initial loss of a neutral ketene and 
subsequent loss of H2O to yield (2) (Figure 1). The heat of the injection port was 
sufficient to fully convert (1) to (2). Compound (2) was also confirmed as the pyrolysis 
product of in-house synthesised (1) in separate experiments using a heat gun at a much 
higher temperatures (supplemental data 3). When APAAN was subjected to similar 
pyrolysis experiments using the heat gun (to ensure a higher temperature than just that 
of the GCMS analytical method) it did not form compound (2) which confirmed that (1) 
had to be formed first and it alone led to the formation of (2). 
Structurally, APAAN can be regarded as alpha-substituted benzyl cyanide and oxidative 
homo-coupling results in the formation of a new carbon - carbon bond between the two 
carbons alpha to the carbonitrile functional groups, i.e. resulting in the formation of (1). 
This APAAN dimerization resulted in the formation of both dl and meso isomers of (1) 
because these type of transformations generally undergo non-diasteroselective radical 
dimerization processes.[13] Utilizing the differences in solubility of the isomeric forms in 
the preparative TLC work up, the dl isomer was preferentially isolated. The 1H NMR and 
13C NMR data further confirmed identification of (1) and (2). Interestingly, the 1H NMR of 
(1), if isomerically pure for either dl and meso isomers, would only have one signal 
for both methyl groups present but two methyl signals in the ratio of 90:10 were 
observed for (1) which reflected the greater abundance of the dl isomer of (1) following 
implementation of preparative TLC (supplemental data 4). In the synthesis of the 
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structurally similar 2,3-diphenyl-succinonitrile, a mixture of meso and dl isomers is also 
reported and the synthesis method was altered to favor production of the meso 
isomer.[14] The high resolution electrospray mass spectrometry data for (1) gave an 
accurate mass of 317.1281 consistent with C20H17N2O2 at m/z 317.1285. LCMS data of 
(1) in the presence of the APAAN acidic hydrolysis products is shown in supplemental 
data 2. Also included are in-source collision induced dissociation spectra at fragmentor 
voltages of 50 V and 130 V, provided suitable formation of product ions and the 
presence of [M + H]+ and [M + Na]+ species.  
 
The GCMS chromatogram of a typical APAAN acidic hydrolysis experiment is presented 
in Figure 2A. The mass spectrum of (2) at retention time of 18.01 min showed a base 
peak at m/z 256, a large peak at m/z 255 (loss of hydrogen from m/z 256), m/z 241 (loss 
of CH3 from m/z 256), m/z 214 (loss of HCN from m/z 241), 178  (loss of phenyl group 
and a hydrogen from m/z 256 and subsequent rearrangement) and m/z 151 (loss of 
HCN from m/z 178) (Figures 2B and 2C).  
 
LCMS electrospray in-source collision induced dissociation experiments with (2) at 
increasing fragmentor voltages (50, 110, 130 and 150 V) yielded ions at m/z 230 and 
m/z 203 that resulted from two successive loss of HCN from [M + H]+. In addition to the 
protonated molecule, the sodiated adduct was also detected The solid-state crystal 
structures for (1) and (2) wer  obtained by x-ray crystallography and confirmed the 
assignments made (Figure 3, supplemental data 6). 
Compound (2) contains two nitrile groups and the proposed mechanism of formation of 
(2) from (1) by pyrolysis is difficult to envisage by any other mechanism. Compound (2) 
was also unaffected when subjected to acid hydrolysis with various acids, which 
indicated that its presence might have been carried through to the final amphetamine 
product stage including utlilization of the Leuckart reaction conditions. The resistance of 
nitrile groups to acidic hydrolysis in substituted dicarbonitrile heterocyclics has been 
previously reported.[15] In the case of compound (2) the stability of the carbonitriles may 
have been reinforced due to steric hindrance of the attached phenyl and acetyl groups.  
Compound (1) was not detected in the Leuckart syntheses of amphetamine employed in-
house using P2P (generated via APAAN hydrolysis) although compound (2) was 
detected (supplemental data 5). For this reason, compound (2) is therefore proposed as 
a potential route specific marker to the use of APAAN in amphetamine manufacture.  
In illicit manufacturing situations, it might be anticipated that the generation of oxidation 
by-products might become important given the nature of the equipment employed (often 
not specifically designed for chemical processing) and the often less than ideal reagent 
sourcing and storage facilities at illicit production sites. In other words, the potential 
oxidation of APAAN encountered during clandestine situations would predict the trace 
presence of (1) as an impurity in APAAN utilized as the starting material. In the resulting 
illicit amphetamine products and also in waste products there is the potential to observe 
both (1) and (2) in much greater amounts due to the synthesis and processing conditions 
employed at illicit production sites. Consequently, the finding of such compounds and 
their analytical data will be of interest to those involved in investigations of clandestine 
manufacturing facilities. 
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alpha-Methylstyrene (AMS) synthesis to P2P and its by-products 
As previously stated there are many published synthetic routes to P2P.[6] The methods 
most favored by illicit producers utilize common and easily available starting reagents. A 
recently reported method applied to the synthesis of ketones involved the occurrence of 
oxidative 1,2-shifts in 1,1-disubstituted alkenes in the presence of Oxone® and a 
catalytic amount of sodium iodide (NaI).[9,16-18] In the present study,  AMS was used as 
the alkene in the presence of Oxone® and NaI (10 % molar). The progress of the 
reaction was monitored by GCMS until depletion of the AMS starting material.  
Analysis of this reaction product (‘mixture A’) was found to contain 84 % P2P, 
presumably involving the catalytic oxidative 1,2-shift of the phenyl group to yield P2P via 
an iodosyl intermediate generated by the reaction of Oxone® with 1-iodo-2-
phenylpropan-2-ol (Figure 4A). The high yield of P2P and the relative lack of other 
impurities could  make this synthesis route a potential method for illicit producers. Benzyl 
acetate, 1-iodo-2-phenylpropan-2-ol, acetophenone and 2-phenylpropanal were 
identified as minor by-products alongside the major component P2P in ‘mixture A’. 
When the synthesis conditions were changed to increasing amounts of NaI, a dramatic 
change in the ratio of substances obtained in the product was observed. AMS in the 
presence of Oxone® and an equimolar amount of NaI (a ten-fold increase in 
concentration compared to the conditions used to prepare ‘mixture A’) yielded ‘mixture B’ 
which contained only 5 % P2P. It is suggested that in the presence the increased 
amount of NaI, Oxone® reacts with the NaI, reducing the amount of available Oxone® 
and thus considerably reduces the conversion of 1-iodo-2-phenylpropan-2-ol to the 
iodosyl intermediate for further conversion to P2P. Instead 1-Iodo-2-phenylpropan-2-ol 
remained as the major component detected in ‘mixture B’. This mechanism and the 
changes in the major component formed depending on NaI concentration has been 
previously reported.[9]  
 
In ‘mixture A’, the Baeyer-Villiger oxidation of any synthesised P2P via potassium 
peroxymonosulfate (Oxone®) would yield benzyl acetate and this is less likely to occur in 
‘mixture B’ due to the competition from an increased amount of NaI. Interestingly, 
potassium peroxymonosulfate was the then newly discovered oxidant employed by Adolf 
von Baeyer and Victor Villiger in their research into the transformation of ketones into 
esters and cyclic ketones into lactones by peracids in 1899.[19] P2P can be made utilizing 
the Baeyer-Villiger peracetic acid treatment of 2-acetyl-1-phenylprop-1-ene below 30 °C 
that results in the formation of 2-acetoxy-1-phenylprop-1-ene. Heating this crude reaction 
mixture with aqueous HCl at 80 °C was reported to yield P2P.[20] 2-Phenylpropanal, 
another by-product  present  in  ‘mixture  A’,  has  also  been  previously  reported via an 
AMS epoxidation and a subsequent Lewis acid rearrangement.[21] The presence of 
acetophenone observed in catalytic AMS oxidations might have reflected the formation 
of an AMS intermediate carrying a benzylic radical center which convert to a cyclic 
peroxide intermediate. Depending on the reaction conditions, this peroxide intermediate 
may decompose to acetophenone and formaldehyde or to P2P. Catalytic oxidations of 
AMS have been studied intensely and a number of products have been identified 
including linear and cyclic dimers of AMS. Unsaturated linear AMS dimers have been 
found useful in the production of polymers.[22,23] 
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When the ‘mixture A’ was subjected to the Leuckart synthesis, the indene derivative 
1,1,3-trimethyl-3-phenyl-2,3-dihydro-1H-indene (3), i.e. a cyclic AMS dimer, was 
identified as a by-product during amphetamine synthesis. Compound (3) was not 
detected in the AMS starting material. ‘Mixture A’ and P2P derived from the APAAN 
synthesis route were examined and impurity (3) was not detected in either, which 
indicated that (3) was formed during the Leuckart synthesis of ‘mixture A’. Under acidic 
conditions, AMS has been previously reported to form (3).[24] It is therefore suggested, 
that the 1- iodo-2-phenylpropan-2-ol which remained present as a by-product in ‘mixture 
A’, under Leuckart synthesis conditions forms AMS, which, in turn, was converted into 
(3). Furthermore, when isolated 1-iodo-2-phenylpropan-2-ol was subjected to the 
Leuckart reaction conditions, compound (3) was detected which supported the 
suggestion that the conversion of 1-iodo-2-phenylpropan-2-ol to AMS under acidic 
conditions might have occurred (supplemental data 7). Compound (3) is commercially 
available compound and the data obtained during identification was consistent with data 
previously published.[24] The electron ionization mass spectrum of (3) and a proposed 
fragmentation scheme is shown in Figures 4B and 4C. Consequently, this observation 
led to the suggestion that the presence of (3) might be characteristic to the AMS route to 
amphetamine via the Leuckart reaction. 
 
The Leuckart synthesis on ‘mixture A’ also yielded unsymmetrical dimers, by combining 
P2P with 1-phenylethanamine or combining acetophenone with amphetamine resulting 
in formation of 1-phenyl-N-(1-phenylethylidene)propan-2-amine and 1-phenyl-N-(1-
phenylpropan-2-ylidene)ethanamine. Both of these were reduced to the stable 
unsymmetrical dimer 1-phenyl-N-(1-phenylethyl)propan-2- amine (4) (Figure 5). The 
GCMS chromatogram of (4) is provided (supplemental data 8). The presence of (4), 
however, is not characteristic of the AMS route to P2P as it has been previously reported 
as a by-product present in seized samples of amphetamine.[25] 
 
Many illicit producers do not monitor the ratio of reagents carefully and illicit production 
operators tend to have little knowledge about the synthesis process itself thus leading to 
variable product quality. The fact that the concentration of the sodium iodide is critical to 
obtain a high yield of P2P in the Oxone® oxidation of AMS is one obvious disadvantage 
to this synthesis route for small-scale illicit amphetamine production. In the examination 
of Irish custom seizures of imported amphetamine to date no indication has emerged 
that the AMS route has been used. 
 
Conclusion 
 
International control and monitoring of 1-phenyl-2-propanone (P2P), and more recently 
alpha-phenylacetoacetonitrile (APAAN), has forced illicit producers to explore different 
unmonitored compounds that can be converted into more commonly used starting 
materials. This study revealed the presence of (1) as a by-product of oxidation and 
APAAN hydrolysis. This study also revealed the presence of indenes (2) and (3) that 
were found in amphetamine products prepared in-house from P2P, which originated 
from two distinct synthetic routes, i.e. via APAAN hydrolysis and oxidation of alpha-
methylstyrene (AMS). The unsymmetrical dimer (4) was formed as a by-product in the 
Leuckart synthesis of P2P generated from AMS. The presence of compounds 1 – 4 in 
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seized amphetamine samples and waste products could facilitate the suggestion 
whether APAAN or AMS were employed in the synthesis route to the P2P. 
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Figure 1. Compounds (1) and (2) and proposed formation mechanism of (2) 
during pyrolysis of (1).  
 
Figure 2. A: GCMS trace of a representative APAAN hydrolysis to P2P (GC-
MS method 1). B: Electron ionization mass spectrum of compound (2). C: 
Proposed fragmentation pattern of compound (2). 
 
Figure 3. X-ray structures for (1) and (2). 
 
Figure 4. A: 1,2-phenyl shift to yield P2P via an iodosyl intermediate. B: Electron 
ionization mass spectrum of (3). C: Proposed fragmentation pattern of 
compound (3). 
 
Figure 5. Proposed mechanism of formation of compound (4) during Leuckart 
reaction. 
 
 
Supplemental data 
 
1. Synthesis methods for (1), (2), (4) and 1-iodo-2-phenylpropan-2-ol. 
 
2. Assorted analytical data for compounds (1), (2) and APAAN. 
 
3. Analytical data showing that (1) and (2) were present at trace levels in 
commercial APAAN and that the pyrolysis product of (1) is (2). 
 
4. NMR data for (1) (majority of dl form present) and (2). 
 
5. Compound (2) is present in both amphetamine and P2P synthesized from 
APAAN. 
 
6. X-ray CIFs for (1) and (2). 
 
7. Analytical data for conversion of 1-iodo-2-phenyl-propan-2-ol to AMS. 
 
8. Analytical data for (4). 
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